Intawat Nookaew
Concepts (663)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 11 | 2024 | 180 | 2.680 |
Why?
| | Saccharomyces cerevisiae | 19 | 2021 | 166 | 2.640 |
Why?
| | Software | 11 | 2024 | 280 | 1.950 |
Why?
| | Genomics | 14 | 2023 | 271 | 1.850 |
Why?
| | Genome, Fungal | 10 | 2020 | 29 | 1.720 |
Why?
| | Phylogeny | 11 | 2023 | 231 | 1.660 |
Why?
| | Metagenome | 9 | 2024 | 40 | 1.640 |
Why?
| | Genome | 6 | 2022 | 58 | 1.620 |
Why?
| | Bacteria | 14 | 2025 | 226 | 1.520 |
Why?
| | Gene Expression Profiling | 28 | 2024 | 1112 | 1.480 |
Why?
| | Transcriptome | 19 | 2024 | 367 | 1.440 |
Why?
| | Genome, Viral | 6 | 2020 | 78 | 1.430 |
Why?
| | Metabolic Networks and Pathways | 14 | 2021 | 90 | 1.350 |
Why?
| | Osteocytes | 5 | 2024 | 227 | 1.300 |
Why?
| | Computational Biology | 9 | 2024 | 209 | 1.270 |
Why?
| | Sequence Analysis, DNA | 9 | 2024 | 216 | 1.240 |
Why?
| | Models, Biological | 15 | 2020 | 737 | 1.220 |
Why?
| | Metagenomics | 6 | 2024 | 41 | 1.150 |
Why?
| | Nanopores | 3 | 2022 | 3 | 1.040 |
Why?
| | Systems Biology | 8 | 2016 | 33 | 1.030 |
Why?
| | Osteoblasts | 5 | 2025 | 480 | 0.990 |
Why?
| | DNA, Circular | 2 | 2022 | 17 | 0.950 |
Why?
| | Sequence Analysis, RNA | 8 | 2022 | 96 | 0.930 |
Why?
| | Mice | 37 | 2025 | 5982 | 0.900 |
Why?
| | Animals | 52 | 2025 | 13526 | 0.880 |
Why?
| | Gastrointestinal Tract | 10 | 2020 | 110 | 0.870 |
Why?
| | DNA Adducts | 2 | 2025 | 79 | 0.850 |
Why?
| | Periosteum | 1 | 2024 | 25 | 0.830 |
Why?
| | Genetic Variation | 6 | 2020 | 223 | 0.830 |
Why?
| | Databases, Genetic | 9 | 2020 | 82 | 0.810 |
Why?
| | Genome, Bacterial | 12 | 2020 | 60 | 0.750 |
Why?
| | Bone and Bones | 7 | 2025 | 501 | 0.740 |
Why?
| | Mitochondria | 5 | 2025 | 446 | 0.740 |
Why?
| | Lipid Metabolism | 7 | 2019 | 189 | 0.730 |
Why?
| | RNA, Fungal | 2 | 2021 | 18 | 0.730 |
Why?
| | Virulence | 3 | 2020 | 163 | 0.710 |
Why?
| | Streptococcus suis | 1 | 2020 | 1 | 0.680 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2021 | 23 | 0.670 |
Why?
| | Drug Resistance, Microbial | 1 | 2020 | 44 | 0.670 |
Why?
| | Geography | 1 | 2020 | 65 | 0.660 |
Why?
| | Signal Transduction | 13 | 2024 | 1748 | 0.650 |
Why?
| | Oligonucleotide Array Sequence Analysis | 11 | 2018 | 412 | 0.640 |
Why?
| | Herpesviridae | 1 | 2020 | 19 | 0.640 |
Why?
| | Helicobacter pylori | 3 | 2017 | 76 | 0.630 |
Why?
| | Energy Metabolism | 5 | 2023 | 324 | 0.620 |
Why?
| | DNA, Viral | 1 | 2020 | 136 | 0.610 |
Why?
| | Metabolome | 8 | 2019 | 107 | 0.600 |
Why?
| | Saccharomyces cerevisiae Proteins | 5 | 2015 | 131 | 0.550 |
Why?
| | Escherichia coli Proteins | 3 | 2025 | 54 | 0.540 |
Why?
| | Diet | 6 | 2019 | 610 | 0.540 |
Why?
| | Single-Cell Analysis | 3 | 2024 | 72 | 0.540 |
Why?
| | Humans | 66 | 2025 | 53230 | 0.540 |
Why?
| | Eicosapentaenoic Acid | 4 | 2019 | 25 | 0.530 |
Why?
| | Mice, Inbred C57BL | 17 | 2025 | 1925 | 0.520 |
Why?
| | Docosahexaenoic Acids | 4 | 2019 | 32 | 0.520 |
Why?
| | Diet, High-Fat | 7 | 2019 | 243 | 0.520 |
Why?
| | Viruses | 1 | 2017 | 24 | 0.500 |
Why?
| | Penaeidae | 3 | 2021 | 4 | 0.500 |
Why?
| | Head and Neck Neoplasms | 1 | 2019 | 291 | 0.490 |
Why?
| | Proteomics | 3 | 2018 | 336 | 0.480 |
Why?
| | Bone Density | 4 | 2025 | 397 | 0.480 |
Why?
| | Fishes | 3 | 2013 | 25 | 0.450 |
Why?
| | Gastritis, Atrophic | 2 | 2017 | 6 | 0.450 |
Why?
| | Gastric Mucosa | 2 | 2017 | 44 | 0.430 |
Why?
| | RNA, Messenger | 9 | 2022 | 1133 | 0.430 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2020 | 39 | 0.420 |
Why?
| | Adipose Tissue | 2 | 2013 | 210 | 0.420 |
Why?
| | Aspergillus oryzae | 4 | 2017 | 23 | 0.420 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 4 | 2016 | 26 | 0.410 |
Why?
| | Escherichia coli | 3 | 2025 | 183 | 0.400 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2019 | 135 | 0.390 |
Why?
| | Male | 36 | 2025 | 27435 | 0.390 |
Why?
| | Proteome | 5 | 2019 | 177 | 0.390 |
Why?
| | Basal Metabolism | 1 | 2012 | 32 | 0.380 |
Why?
| | Transcription, Genetic | 3 | 2021 | 374 | 0.380 |
Why?
| | Spleen | 3 | 2019 | 166 | 0.380 |
Why?
| | Metabolomics | 4 | 2021 | 155 | 0.370 |
Why?
| | Adjuvants, Immunologic | 3 | 2019 | 52 | 0.360 |
Why?
| | Intestinal Mucosa | 4 | 2025 | 229 | 0.360 |
Why?
| | Osteolysis | 2 | 2022 | 74 | 0.360 |
Why?
| | Multiple Myeloma | 5 | 2024 | 3082 | 0.360 |
Why?
| | Hepatitis C | 2 | 2023 | 82 | 0.350 |
Why?
| | DNA | 4 | 2025 | 535 | 0.350 |
Why?
| | Germinal Center | 2 | 2025 | 29 | 0.350 |
Why?
| | Chlorobi | 1 | 2011 | 2 | 0.340 |
Why?
| | RNA, Ribosomal, 16S | 7 | 2024 | 115 | 0.340 |
Why?
| | Bacteroidetes | 1 | 2011 | 6 | 0.340 |
Why?
| | Lipids | 4 | 2019 | 163 | 0.340 |
Why?
| | Bone Diseases, Metabolic | 2 | 2022 | 79 | 0.340 |
Why?
| | Enterotoxigenic Escherichia coli | 2 | 2022 | 4 | 0.340 |
Why?
| | Glioma | 2 | 2023 | 83 | 0.340 |
Why?
| | Meiosis | 2 | 2021 | 62 | 0.340 |
Why?
| | Biology | 1 | 2010 | 8 | 0.340 |
Why?
| | Female | 33 | 2025 | 28782 | 0.340 |
Why?
| | Sterols | 1 | 2010 | 9 | 0.330 |
Why?
| | Reproducibility of Results | 11 | 2020 | 1219 | 0.330 |
Why?
| | Bone Resorption | 2 | 2023 | 304 | 0.330 |
Why?
| | Gene Expression Regulation | 15 | 2020 | 1003 | 0.320 |
Why?
| | Gene Regulatory Networks | 4 | 2021 | 112 | 0.320 |
Why?
| | T-Lymphocytes | 5 | 2023 | 321 | 0.320 |
Why?
| | Cell Lineage | 3 | 2025 | 90 | 0.320 |
Why?
| | Cytokines | 5 | 2023 | 627 | 0.310 |
Why?
| | Mice, Knockout | 5 | 2025 | 910 | 0.300 |
Why?
| | Phospholipids | 3 | 2021 | 59 | 0.300 |
Why?
| | RNA Interference | 2 | 2019 | 181 | 0.300 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2022 | 212 | 0.300 |
Why?
| | RNA | 4 | 2022 | 173 | 0.290 |
Why?
| | Osteogenesis | 5 | 2025 | 374 | 0.290 |
Why?
| | Aged | 15 | 2024 | 10429 | 0.290 |
Why?
| | Aging | 2 | 2025 | 714 | 0.280 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 96 | 0.280 |
Why?
| | HIV Infections | 2 | 2023 | 402 | 0.280 |
Why?
| | Algorithms | 4 | 2024 | 667 | 0.280 |
Why?
| | Cell Differentiation | 6 | 2022 | 681 | 0.280 |
Why?
| | Bifidobacterium | 2 | 2020 | 5 | 0.280 |
Why?
| | Liver Neoplasms | 2 | 2022 | 346 | 0.270 |
Why?
| | Brain Neoplasms | 2 | 2023 | 319 | 0.270 |
Why?
| | Tumor Microenvironment | 3 | 2024 | 274 | 0.270 |
Why?
| | Microcephaly | 2 | 2018 | 40 | 0.270 |
Why?
| | Proteins | 1 | 2010 | 351 | 0.270 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 42 | 0.270 |
Why?
| | MicroRNAs | 3 | 2019 | 397 | 0.260 |
Why?
| | Plant Extracts | 2 | 2020 | 200 | 0.260 |
Why?
| | NAD | 2 | 2025 | 45 | 0.260 |
Why?
| | Internet | 5 | 2017 | 265 | 0.260 |
Why?
| | Osteoclasts | 4 | 2024 | 428 | 0.260 |
Why?
| | Cell Proliferation | 3 | 2025 | 1031 | 0.250 |
Why?
| | Autophagy | 2 | 2025 | 199 | 0.250 |
Why?
| | Feces | 4 | 2020 | 159 | 0.250 |
Why?
| | Polymerase Chain Reaction | 4 | 2021 | 452 | 0.240 |
Why?
| | Immune System | 3 | 2016 | 41 | 0.240 |
Why?
| | Malates | 3 | 2017 | 7 | 0.240 |
Why?
| | Neutrophils | 2 | 2019 | 153 | 0.240 |
Why?
| | Populus | 2 | 2015 | 7 | 0.240 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2020 | 505 | 0.240 |
Why?
| | Middle Aged | 13 | 2021 | 13419 | 0.230 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2025 | 18 | 0.230 |
Why?
| | Arachidonic Acid | 3 | 2020 | 34 | 0.230 |
Why?
| | Dietary Fiber | 1 | 2025 | 27 | 0.230 |
Why?
| | Recombination, Genetic | 3 | 2021 | 95 | 0.230 |
Why?
| | Mutation | 4 | 2025 | 1337 | 0.230 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2018 | 591 | 0.220 |
Why?
| | Plasmids | 3 | 2020 | 164 | 0.220 |
Why?
| | Hemiptera | 2 | 2021 | 7 | 0.220 |
Why?
| | Herpesvirus 4, Human | 1 | 2025 | 44 | 0.220 |
Why?
| | Rhadinovirus | 1 | 2025 | 22 | 0.220 |
Why?
| | Virus Latency | 1 | 2025 | 53 | 0.220 |
Why?
| | Cell Division | 1 | 2025 | 289 | 0.220 |
Why?
| | Chromosome Mapping | 3 | 2017 | 145 | 0.220 |
Why?
| | Isocitrate Dehydrogenase | 2 | 2023 | 21 | 0.210 |
Why?
| | Homeodomain Proteins | 2 | 2022 | 81 | 0.210 |
Why?
| | Chemokine CXCL12 | 1 | 2024 | 35 | 0.210 |
Why?
| | Leukocytes, Mononuclear | 2 | 2022 | 122 | 0.210 |
Why?
| | Biomass | 3 | 2015 | 22 | 0.210 |
Why?
| | Carcinoma, Renal Cell | 2 | 2016 | 112 | 0.210 |
Why?
| | Aquaculture | 2 | 2021 | 4 | 0.210 |
Why?
| | Chondrocytes | 1 | 2024 | 40 | 0.210 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 868 | 0.210 |
Why?
| | Adipose Tissue, White | 3 | 2019 | 35 | 0.210 |
Why?
| | Thailand | 2 | 2020 | 7 | 0.210 |
Why?
| | B-Lymphocytes | 1 | 2025 | 178 | 0.210 |
Why?
| | Bacteriological Techniques | 2 | 2020 | 38 | 0.200 |
Why?
| | Antiviral Agents | 2 | 2023 | 179 | 0.200 |
Why?
| | Oligodendroglioma | 1 | 2023 | 6 | 0.200 |
Why?
| | Transcription Factors | 9 | 2023 | 571 | 0.200 |
Why?
| | Inflammation | 6 | 2023 | 652 | 0.200 |
Why?
| | Organ Specificity | 2 | 2016 | 115 | 0.200 |
Why?
| | Adenine | 2 | 2021 | 29 | 0.200 |
Why?
| | Astrocytoma | 1 | 2023 | 19 | 0.200 |
Why?
| | Genome Size | 3 | 2020 | 7 | 0.200 |
Why?
| | Cell Line, Tumor | 6 | 2024 | 1470 | 0.200 |
Why?
| | Staphylococcus aureus | 3 | 2021 | 313 | 0.200 |
Why?
| | Cell Line | 3 | 2021 | 1016 | 0.200 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 421 | 0.200 |
Why?
| | Rhamnaceae | 1 | 2023 | 1 | 0.200 |
Why?
| | Genome, Chloroplast | 1 | 2023 | 2 | 0.200 |
Why?
| | Molecular Sequence Data | 5 | 2018 | 759 | 0.200 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2025 | 228 | 0.190 |
Why?
| | Eukaryotic Cells | 1 | 2022 | 15 | 0.190 |
Why?
| | Microbial Sensitivity Tests | 2 | 2020 | 274 | 0.190 |
Why?
| | Pilot Projects | 3 | 2020 | 726 | 0.190 |
Why?
| | Base Sequence | 4 | 2021 | 620 | 0.190 |
Why?
| | Oxidative Phosphorylation | 2 | 2020 | 48 | 0.190 |
Why?
| | Bone Neoplasms | 1 | 2024 | 188 | 0.190 |
Why?
| | Pichia | 2 | 2012 | 8 | 0.190 |
Why?
| | Hepatitis C, Chronic | 1 | 2023 | 89 | 0.190 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2022 | 10 | 0.190 |
Why?
| | Escherichia coli Infections | 1 | 2022 | 28 | 0.190 |
Why?
| | Estrogens | 2 | 2022 | 224 | 0.190 |
Why?
| | Cyclic AMP | 1 | 2022 | 91 | 0.190 |
Why?
| | Gene Expression Regulation, Bacterial | 2 | 2025 | 177 | 0.180 |
Why?
| | Data Interpretation, Statistical | 2 | 2013 | 169 | 0.180 |
Why?
| | Chemotaxis | 2 | 2019 | 21 | 0.180 |
Why?
| | Principal Component Analysis | 4 | 2016 | 53 | 0.180 |
Why?
| | Phenotype | 5 | 2023 | 803 | 0.180 |
Why?
| | Spermatozoa | 1 | 2021 | 29 | 0.180 |
Why?
| | Chromosomes, Human | 1 | 2021 | 41 | 0.180 |
Why?
| | Quinoxalines | 1 | 2021 | 26 | 0.180 |
Why?
| | Cell Communication | 1 | 2022 | 73 | 0.180 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 350 | 0.180 |
Why?
| | Benzofurans | 1 | 2021 | 19 | 0.180 |
Why?
| | Case-Control Studies | 8 | 2018 | 1212 | 0.180 |
Why?
| | Neck Pain | 1 | 2021 | 10 | 0.170 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 45 | 0.170 |
Why?
| | Adenosine Triphosphate | 2 | 2020 | 211 | 0.170 |
Why?
| | Back Pain | 1 | 2021 | 40 | 0.170 |
Why?
| | Coinfection | 1 | 2021 | 41 | 0.170 |
Why?
| | User-Computer Interface | 3 | 2017 | 80 | 0.170 |
Why?
| | Templates, Genetic | 1 | 2021 | 11 | 0.170 |
Why?
| | Arthralgia | 1 | 2021 | 44 | 0.170 |
Why?
| | RNA, Ribosomal | 1 | 2021 | 16 | 0.170 |
Why?
| | Triglycerides | 2 | 2019 | 171 | 0.170 |
Why?
| | Imidoesters | 1 | 2020 | 2 | 0.170 |
Why?
| | Netherlands | 1 | 2020 | 17 | 0.170 |
Why?
| | Swine Diseases | 1 | 2020 | 7 | 0.170 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 46 | 0.170 |
Why?
| | Methyltransferases | 1 | 2021 | 28 | 0.170 |
Why?
| | RNA, Bacterial | 1 | 2021 | 53 | 0.170 |
Why?
| | Nucleotide Motifs | 1 | 2021 | 22 | 0.170 |
Why?
| | Imidazoles | 1 | 2021 | 114 | 0.170 |
Why?
| | Host-Pathogen Interactions | 2 | 2019 | 135 | 0.170 |
Why?
| | Canada | 1 | 2020 | 112 | 0.160 |
Why?
| | Surface Properties | 1 | 2020 | 61 | 0.160 |
Why?
| | Lactobacillus plantarum | 1 | 2020 | 1 | 0.160 |
Why?
| | Stereoisomerism | 1 | 2020 | 101 | 0.160 |
Why?
| | Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.160 |
Why?
| | China | 1 | 2020 | 135 | 0.160 |
Why?
| | Muscle, Skeletal | 3 | 2016 | 815 | 0.160 |
Why?
| | Adult | 11 | 2022 | 14534 | 0.160 |
Why?
| | Particle Size | 1 | 2020 | 76 | 0.160 |
Why?
| | DNA Modification Methylases | 1 | 2020 | 29 | 0.160 |
Why?
| | Mortierella | 1 | 2020 | 1 | 0.160 |
Why?
| | Acetyl Coenzyme A | 1 | 2020 | 6 | 0.160 |
Why?
| | ROC Curve | 1 | 2021 | 246 | 0.160 |
Why?
| | DNA Repair Enzymes | 1 | 2020 | 44 | 0.160 |
Why?
| | Streptococcal Infections | 1 | 2020 | 49 | 0.160 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 99 | 0.160 |
Why?
| | Alum Compounds | 1 | 2019 | 3 | 0.160 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 184 | 0.160 |
Why?
| | Molecular Structure | 1 | 2020 | 320 | 0.150 |
Why?
| | Colitis | 1 | 2020 | 49 | 0.150 |
Why?
| | Helicobacter Infections | 2 | 2017 | 77 | 0.150 |
Why?
| | Neoplasms | 2 | 2025 | 1334 | 0.150 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2023 | 205 | 0.150 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 130 | 0.150 |
Why?
| | Mumps virus | 1 | 2019 | 10 | 0.150 |
Why?
| | Mumps | 1 | 2019 | 13 | 0.150 |
Why?
| | Cannabidiol | 1 | 2020 | 44 | 0.150 |
Why?
| | Computer Simulation | 5 | 2013 | 290 | 0.150 |
Why?
| | Cytoskeleton | 1 | 2019 | 39 | 0.150 |
Why?
| | Swine | 1 | 2020 | 440 | 0.150 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 166 | 0.150 |
Why?
| | Databases, Protein | 3 | 2015 | 28 | 0.150 |
Why?
| | Glycocholic Acid | 1 | 2019 | 1 | 0.150 |
Why?
| | Stress, Mechanical | 1 | 2019 | 95 | 0.150 |
Why?
| | Cholagogues and Choleretics | 1 | 2019 | 5 | 0.150 |
Why?
| | Ion Channels | 1 | 2019 | 70 | 0.150 |
Why?
| | Anti-Obesity Agents | 1 | 2019 | 16 | 0.150 |
Why?
| | Tea | 1 | 2019 | 17 | 0.150 |
Why?
| | Preservation, Biological | 1 | 2018 | 9 | 0.150 |
Why?
| | Microbial Viability | 2 | 2017 | 31 | 0.150 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2019 | 333 | 0.150 |
Why?
| | Cell Death | 1 | 2019 | 171 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 133 | 0.140 |
Why?
| | Disease Models, Animal | 6 | 2023 | 1517 | 0.140 |
Why?
| | Liver | 5 | 2019 | 1150 | 0.140 |
Why?
| | Sensitivity and Specificity | 2 | 2020 | 867 | 0.140 |
Why?
| | Disease Outbreaks | 1 | 2019 | 120 | 0.140 |
Why?
| | Chronic Pain | 1 | 2021 | 183 | 0.140 |
Why?
| | Molecular Sequence Annotation | 4 | 2020 | 28 | 0.140 |
Why?
| | Prediabetic State | 1 | 2018 | 22 | 0.140 |
Why?
| | 5' Untranslated Regions | 1 | 2018 | 29 | 0.140 |
Why?
| | Cecum | 1 | 2018 | 62 | 0.140 |
Why?
| | Bacterial Physiological Phenomena | 2 | 2020 | 6 | 0.140 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2018 | 86 | 0.140 |
Why?
| | Cell Movement | 1 | 2019 | 279 | 0.140 |
Why?
| | 3' Untranslated Regions | 1 | 2018 | 55 | 0.140 |
Why?
| | Duodenum | 1 | 2017 | 34 | 0.130 |
Why?
| | Obesity | 3 | 2016 | 1204 | 0.130 |
Why?
| | Cell Adhesion | 2 | 2015 | 163 | 0.130 |
Why?
| | Epithelial Cells | 2 | 2019 | 218 | 0.130 |
Why?
| | Calcium | 2 | 2016 | 373 | 0.130 |
Why?
| | Gene Expression | 3 | 2019 | 618 | 0.130 |
Why?
| | Cannabis | 1 | 2020 | 155 | 0.130 |
Why?
| | Neural Stem Cells | 1 | 2017 | 33 | 0.130 |
Why?
| | Tandem Repeat Sequences | 1 | 2017 | 7 | 0.130 |
Why?
| | Eukaryota | 1 | 2017 | 11 | 0.130 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2018 | 83 | 0.130 |
Why?
| | Lipid A | 1 | 2016 | 4 | 0.130 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2016 | 27 | 0.130 |
Why?
| | Colitis, Ulcerative | 1 | 2017 | 68 | 0.130 |
Why?
| | Sequence Alignment | 1 | 2017 | 119 | 0.130 |
Why?
| | Glucosides | 1 | 2016 | 21 | 0.130 |
Why?
| | Fungal Proteins | 3 | 2017 | 110 | 0.130 |
Why?
| | Stomach | 1 | 2017 | 80 | 0.130 |
Why?
| | Genes, Fungal | 2 | 2013 | 23 | 0.130 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2016 | 39 | 0.130 |
Why?
| | Protein Biosynthesis | 1 | 2019 | 268 | 0.120 |
Why?
| | Autoimmunity | 2 | 2016 | 34 | 0.120 |
Why?
| | Muscle Relaxation | 1 | 2016 | 15 | 0.120 |
Why?
| | Protein Conformation | 1 | 2017 | 174 | 0.120 |
Why?
| | Immunization | 2 | 2019 | 69 | 0.120 |
Why?
| | Meat | 2 | 2013 | 60 | 0.120 |
Why?
| | Glycosaminoglycans | 1 | 2016 | 19 | 0.120 |
Why?
| | Nitrogen | 2 | 2013 | 70 | 0.120 |
Why?
| | Microwaves | 2 | 2013 | 10 | 0.120 |
Why?
| | DNA, Bacterial | 2 | 2020 | 167 | 0.120 |
Why?
| | Oligopeptides | 1 | 2016 | 94 | 0.120 |
Why?
| | Adhesins, Bacterial | 1 | 2016 | 27 | 0.120 |
Why?
| | Inositol | 2 | 2013 | 19 | 0.120 |
Why?
| | Running | 1 | 2016 | 23 | 0.120 |
Why?
| | Pseudomonas | 1 | 2015 | 5 | 0.120 |
Why?
| | Melanoma, Experimental | 1 | 2016 | 34 | 0.120 |
Why?
| | Mice, Transgenic | 3 | 2023 | 561 | 0.120 |
Why?
| | Breast Neoplasms | 1 | 2024 | 1222 | 0.120 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 324 | 0.120 |
Why?
| | Aorta, Thoracic | 1 | 2016 | 101 | 0.120 |
Why?
| | Ebolavirus | 1 | 2015 | 5 | 0.120 |
Why?
| | Cluster Analysis | 5 | 2014 | 237 | 0.120 |
Why?
| | Metabolic Engineering | 2 | 2014 | 5 | 0.110 |
Why?
| | Flocculation | 1 | 2015 | 1 | 0.110 |
Why?
| | Conjugation, Genetic | 1 | 2015 | 2 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2021 | 622 | 0.110 |
Why?
| | Mannose-Binding Lectins | 1 | 2015 | 7 | 0.110 |
Why?
| | Comparative Genomic Hybridization | 2 | 2015 | 38 | 0.110 |
Why?
| | Muscle Cells | 1 | 2015 | 20 | 0.110 |
Why?
| | Adipocytes | 2 | 2013 | 131 | 0.110 |
Why?
| | Killer Cells, Natural | 1 | 2016 | 113 | 0.110 |
Why?
| | Plant Proteins | 1 | 2015 | 72 | 0.110 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2014 | 4 | 0.110 |
Why?
| | Bacterial Load | 1 | 2014 | 11 | 0.110 |
Why?
| | Fatty Acids | 2 | 2013 | 154 | 0.110 |
Why?
| | Interleukin-6 | 1 | 2016 | 272 | 0.110 |
Why?
| | Kidney Neoplasms | 1 | 2016 | 181 | 0.110 |
Why?
| | Fermentation | 3 | 2025 | 14 | 0.110 |
Why?
| | Database Management Systems | 1 | 2014 | 27 | 0.110 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2013 | 49 | 0.110 |
Why?
| | Blood Glucose | 2 | 2016 | 490 | 0.110 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2014 | 18 | 0.110 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 210 | 0.100 |
Why?
| | Stomach Neoplasms | 1 | 2017 | 207 | 0.100 |
Why?
| | Osteoporosis | 2 | 2025 | 159 | 0.100 |
Why?
| | Fatty Liver | 1 | 2015 | 145 | 0.100 |
Why?
| | Loss of Heterozygosity | 1 | 2014 | 78 | 0.100 |
Why?
| | Myocardial Infarction | 1 | 2018 | 445 | 0.100 |
Why?
| | DNA Methylation | 1 | 2018 | 592 | 0.100 |
Why?
| | Models, Theoretical | 2 | 2013 | 180 | 0.100 |
Why?
| | Cells, Cultured | 3 | 2025 | 1569 | 0.100 |
Why?
| | Health | 1 | 2013 | 21 | 0.100 |
Why?
| | Penicillium chrysogenum | 1 | 2013 | 1 | 0.100 |
Why?
| | Fungi | 1 | 2013 | 51 | 0.100 |
Why?
| | Glucose Intolerance | 1 | 2013 | 27 | 0.100 |
Why?
| | Genes | 1 | 2013 | 30 | 0.100 |
Why?
| | Blood Vessels | 1 | 2013 | 73 | 0.100 |
Why?
| | Carbon Isotopes | 4 | 2014 | 73 | 0.100 |
Why?
| | United States | 2 | 2021 | 5409 | 0.100 |
Why?
| | Adipocytes, Brown | 1 | 2012 | 9 | 0.100 |
Why?
| | Open Reading Frames | 2 | 2013 | 52 | 0.100 |
Why?
| | INDEL Mutation | 1 | 2012 | 4 | 0.100 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 7 | 0.090 |
Why?
| | Biosynthetic Pathways | 3 | 2020 | 6 | 0.090 |
Why?
| | Industrial Microbiology | 1 | 2012 | 2 | 0.090 |
Why?
| | Multiple Sclerosis | 1 | 2013 | 77 | 0.090 |
Why?
| | Methyl Ethers | 1 | 2012 | 17 | 0.090 |
Why?
| | Aldehyde-Lyases | 1 | 2012 | 1 | 0.090 |
Why?
| | Aspergillus nidulans | 1 | 2012 | 4 | 0.090 |
Why?
| | Leukocytes | 1 | 2012 | 58 | 0.090 |
Why?
| | Choline | 1 | 2012 | 64 | 0.090 |
Why?
| | Hepacivirus | 2 | 2023 | 105 | 0.090 |
Why?
| | Staphylococcal Infections | 1 | 2014 | 271 | 0.090 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2011 | 32 | 0.090 |
Why?
| | Yeasts | 1 | 2011 | 8 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2013 | 282 | 0.090 |
Why?
| | Sex Characteristics | 1 | 2012 | 204 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2018 | 563 | 0.090 |
Why?
| | Vagina | 1 | 2011 | 45 | 0.080 |
Why?
| | Gene Deletion | 2 | 2010 | 279 | 0.080 |
Why?
| | Phosphoglycerate Mutase | 1 | 2010 | 1 | 0.080 |
Why?
| | Bone Marrow | 1 | 2012 | 359 | 0.080 |
Why?
| | Adipocytes, White | 1 | 2010 | 3 | 0.080 |
Why?
| | Aspergillus niger | 1 | 2010 | 6 | 0.080 |
Why?
| | Homeostasis | 2 | 2023 | 209 | 0.080 |
Why?
| | Peptidoglycan | 2 | 2025 | 16 | 0.080 |
Why?
| | Time Factors | 4 | 2019 | 2991 | 0.080 |
Why?
| | RANK Ligand | 2 | 2022 | 188 | 0.080 |
Why?
| | Genotype | 2 | 2023 | 563 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2021 | 147 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2012 | 224 | 0.070 |
Why?
| | Microarray Analysis | 3 | 2015 | 69 | 0.070 |
Why?
| | Drug Combinations | 2 | 2021 | 138 | 0.070 |
Why?
| | Immunity, Innate | 2 | 2020 | 112 | 0.070 |
Why?
| | Pregnancy | 4 | 2018 | 2608 | 0.070 |
Why?
| | RNA, Transfer | 1 | 2008 | 13 | 0.070 |
Why?
| | Corn Oil | 2 | 2019 | 12 | 0.070 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2013 | 71 | 0.070 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2013 | 181 | 0.070 |
Why?
| | Antigens, Bacterial | 2 | 2019 | 55 | 0.070 |
Why?
| | Energy Transfer | 1 | 2007 | 2 | 0.070 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 245 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 1723 | 0.070 |
Why?
| | Multilocus Sequence Typing | 2 | 2018 | 7 | 0.070 |
Why?
| | Young Adult | 4 | 2020 | 4511 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2018 | 135 | 0.060 |
Why?
| | Lymphocyte Activation | 2 | 2020 | 163 | 0.060 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2019 | 29 | 0.060 |
Why?
| | Codon | 2 | 2017 | 42 | 0.060 |
Why?
| | Infant | 3 | 2020 | 3805 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2013 | 3494 | 0.060 |
Why?
| | Bayes Theorem | 2 | 2017 | 120 | 0.060 |
Why?
| | Organ Size | 2 | 2016 | 226 | 0.060 |
Why?
| | Fatty Acids, Volatile | 1 | 2025 | 16 | 0.060 |
Why?
| | Tandem Mass Spectrometry | 2 | 2018 | 254 | 0.060 |
Why?
| | Child | 4 | 2022 | 7379 | 0.060 |
Why?
| | Superoxide Dismutase | 1 | 2025 | 122 | 0.060 |
Why?
| | Cell Wall | 1 | 2025 | 59 | 0.060 |
Why?
| | Lysosomes | 1 | 2025 | 68 | 0.060 |
Why?
| | Femur | 1 | 2025 | 133 | 0.060 |
Why?
| | Tumor Virus Infections | 1 | 2025 | 46 | 0.060 |
Why?
| | NF-kappa B | 2 | 2017 | 327 | 0.060 |
Why?
| | Herpesviridae Infections | 1 | 2025 | 57 | 0.050 |
Why?
| | Arkansas | 2 | 2021 | 2068 | 0.050 |
Why?
| | Interleukin-18 | 1 | 2024 | 26 | 0.050 |
Why?
| | Coenzyme A-Transferases | 1 | 2023 | 1 | 0.050 |
Why?
| | Myeloid Progenitor Cells | 1 | 2023 | 15 | 0.050 |
Why?
| | Chromosomes, Human, Pair 19 | 1 | 2023 | 8 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 1544 | 0.050 |
Why?
| | Osteoprotegerin | 1 | 2023 | 53 | 0.050 |
Why?
| | Bacterial Proteins | 2 | 2018 | 347 | 0.050 |
Why?
| | Eating | 1 | 2024 | 159 | 0.050 |
Why?
| | Chloroplasts | 1 | 2023 | 4 | 0.050 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2023 | 11 | 0.050 |
Why?
| | Cattle | 2 | 2013 | 207 | 0.050 |
Why?
| | DNA Damage | 1 | 2025 | 309 | 0.050 |
Why?
| | Absorptiometry, Photon | 2 | 2013 | 160 | 0.050 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2023 | 95 | 0.050 |
Why?
| | TNF Receptor-Associated Factor 3 | 1 | 2022 | 13 | 0.050 |
Why?
| | Cystatin M | 1 | 2022 | 17 | 0.050 |
Why?
| | Fucose | 1 | 2022 | 1 | 0.050 |
Why?
| | Culture Media | 2 | 2013 | 97 | 0.050 |
Why?
| | Putrescine | 1 | 2022 | 4 | 0.050 |
Why?
| | Genome, Human | 2 | 2013 | 121 | 0.050 |
Why?
| | Carbon | 2 | 2013 | 60 | 0.050 |
Why?
| | Neurotransmitter Agents | 1 | 2022 | 32 | 0.050 |
Why?
| | Glycolysis | 2 | 2013 | 76 | 0.050 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2022 | 46 | 0.050 |
Why?
| | Prognosis | 2 | 2021 | 2118 | 0.050 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 50 | 0.050 |
Why?
| | Amino Acids, Essential | 1 | 2024 | 141 | 0.050 |
Why?
| | Ovariectomy | 1 | 2022 | 114 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2020 | 2913 | 0.050 |
Why?
| | Alu Elements | 1 | 2021 | 7 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2023 | 333 | 0.050 |
Why?
| | Tryptophan | 1 | 2022 | 89 | 0.050 |
Why?
| | Genes, Essential | 1 | 2021 | 11 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 2021 | 24 | 0.040 |
Why?
| | Gene Library | 1 | 2021 | 40 | 0.040 |
Why?
| | Suramin | 1 | 2021 | 10 | 0.040 |
Why?
| | Apoptosis | 2 | 2020 | 1139 | 0.040 |
Why?
| | Viral Load | 1 | 2021 | 83 | 0.040 |
Why?
| | Sulfoxides | 1 | 2021 | 22 | 0.040 |
Why?
| | DNA Transposable Elements | 1 | 2021 | 107 | 0.040 |
Why?
| | Iron | 1 | 2022 | 130 | 0.040 |
Why?
| | Isothiocyanates | 1 | 2021 | 21 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2021 | 97 | 0.040 |
Why?
| | Rats | 2 | 2018 | 3162 | 0.040 |
Why?
| | Chromosomes | 1 | 2021 | 28 | 0.040 |
Why?
| | Enterococcus | 1 | 2020 | 9 | 0.040 |
Why?
| | Clostridium | 1 | 2020 | 16 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2023 | 774 | 0.040 |
Why?
| | Adolescent | 3 | 2017 | 6907 | 0.040 |
Why?
| | Amino Acids | 2 | 2013 | 382 | 0.040 |
Why?
| | Food Safety | 1 | 2020 | 3 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2023 | 333 | 0.040 |
Why?
| | Alcohol Oxidoreductases | 1 | 2020 | 13 | 0.040 |
Why?
| | Mucin-2 | 1 | 2020 | 8 | 0.040 |
Why?
| | Cohort Studies | 2 | 2016 | 1557 | 0.040 |
Why?
| | gamma-Linolenic Acid | 1 | 2020 | 1 | 0.040 |
Why?
| | Fatty Acid Desaturases | 1 | 2020 | 9 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2021 | 116 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2021 | 466 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 141 | 0.040 |
Why?
| | Mucorales | 1 | 2020 | 12 | 0.040 |
Why?
| | Methylation | 1 | 2020 | 127 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2024 | 479 | 0.040 |
Why?
| | Chemokines | 1 | 2020 | 78 | 0.040 |
Why?
| | Dydrogesterone | 1 | 2019 | 1 | 0.040 |
Why?
| | Tuberculosis Vaccines | 1 | 2019 | 1 | 0.040 |
Why?
| | Disease Resistance | 1 | 2019 | 10 | 0.040 |
Why?
| | Lentivirus | 1 | 2019 | 17 | 0.040 |
Why?
| | Workflow | 1 | 2020 | 53 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 2019 | 44 | 0.040 |
Why?
| | Transgenes | 1 | 2019 | 55 | 0.040 |
Why?
| | Colon | 1 | 2020 | 106 | 0.040 |
Why?
| | Indoles | 1 | 2022 | 280 | 0.040 |
Why?
| | Mumps Vaccine | 1 | 2019 | 5 | 0.040 |
Why?
| | Ovary | 1 | 2020 | 103 | 0.040 |
Why?
| | Child, Preschool | 2 | 2020 | 4162 | 0.040 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2019 | 50 | 0.040 |
Why?
| | Neutralization Tests | 1 | 2019 | 26 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2019 | 98 | 0.040 |
Why?
| | Nanofibers | 1 | 2019 | 8 | 0.040 |
Why?
| | Focal Adhesions | 1 | 2019 | 17 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2019 | 96 | 0.040 |
Why?
| | PPAR alpha | 1 | 2019 | 61 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2019 | 163 | 0.040 |
Why?
| | Actin Cytoskeleton | 1 | 2019 | 22 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 109 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 51 | 0.040 |
Why?
| | Lung | 1 | 2023 | 481 | 0.040 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2019 | 64 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2019 | 127 | 0.040 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2023 | 647 | 0.040 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 30 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 235 | 0.040 |
Why?
| | Caco-2 Cells | 1 | 2019 | 31 | 0.040 |
Why?
| | Bacterial Adhesion | 1 | 2019 | 17 | 0.040 |
Why?
| | Thinness | 1 | 2019 | 44 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2019 | 78 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2019 | 109 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2019 | 116 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 949 | 0.040 |
Why?
| | Bacteroides | 1 | 2018 | 14 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 23 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2019 | 187 | 0.040 |
Why?
| | Specimen Handling | 1 | 2018 | 63 | 0.040 |
Why?
| | Medicaid | 1 | 2021 | 294 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2019 | 294 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2019 | 187 | 0.030 |
Why?
| | Biopsy | 1 | 2020 | 600 | 0.030 |
Why?
| | Africa | 1 | 2017 | 13 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2020 | 195 | 0.030 |
Why?
| | Asia | 1 | 2017 | 24 | 0.030 |
Why?
| | Temperature | 1 | 2018 | 165 | 0.030 |
Why?
| | Superoxides | 1 | 2018 | 46 | 0.030 |
Why?
| | Brazil | 1 | 2017 | 39 | 0.030 |
Why?
| | Physicians | 1 | 2021 | 242 | 0.030 |
Why?
| | Gene Dosage | 1 | 2018 | 76 | 0.030 |
Why?
| | Selection, Genetic | 1 | 2017 | 27 | 0.030 |
Why?
| | Synteny | 1 | 2017 | 7 | 0.030 |
Why?
| | RNA Stability | 1 | 2017 | 29 | 0.030 |
Why?
| | Clostridium thermocellum | 1 | 2017 | 3 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 638 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2018 | 52 | 0.030 |
Why?
| | Neurogenesis | 1 | 2017 | 29 | 0.030 |
Why?
| | Computer Graphics | 1 | 2017 | 9 | 0.030 |
Why?
| | Clostridium Infections | 1 | 2018 | 56 | 0.030 |
Why?
| | Erythropoiesis | 1 | 2017 | 18 | 0.030 |
Why?
| | Leukotrienes | 1 | 2017 | 9 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 109 | 0.030 |
Why?
| | Systems Analysis | 1 | 2016 | 8 | 0.030 |
Why?
| | Prostaglandins | 1 | 2017 | 21 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 423 | 0.030 |
Why?
| | Aorta | 1 | 2018 | 172 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2016 | 32 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2017 | 69 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 533 | 0.030 |
Why?
| | Nicaragua | 1 | 2016 | 2 | 0.030 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2016 | 3 | 0.030 |
Why?
| | Mitochondria, Muscle | 1 | 2016 | 43 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2016 | 25 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2016 | 86 | 0.030 |
Why?
| | Fasting | 1 | 2016 | 76 | 0.030 |
Why?
| | Pseudomonas fluorescens | 1 | 2015 | 2 | 0.030 |
Why?
| | RNA, Plant | 1 | 2015 | 6 | 0.030 |
Why?
| | Pseudomonas putida | 1 | 2015 | 3 | 0.030 |
Why?
| | Staining and Labeling | 1 | 2016 | 94 | 0.030 |
Why?
| | Rhizosphere | 1 | 2015 | 4 | 0.030 |
Why?
| | Diploidy | 1 | 2015 | 25 | 0.030 |
Why?
| | Sequence Analysis, Protein | 1 | 2015 | 19 | 0.030 |
Why?
| | Plant Roots | 1 | 2015 | 26 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 64 | 0.030 |
Why?
| | Panicum | 1 | 2015 | 1 | 0.030 |
Why?
| | Cellulase | 1 | 2015 | 2 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1367 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 132 | 0.030 |
Why?
| | Filoviridae | 1 | 2015 | 3 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2015 | 79 | 0.030 |
Why?
| | Epinephrine | 1 | 2016 | 92 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 237 | 0.030 |
Why?
| | Cations, Divalent | 1 | 2015 | 6 | 0.030 |
Why?
| | Plants | 1 | 2015 | 29 | 0.030 |
Why?
| | Pseudomonas aeruginosa | 1 | 2015 | 78 | 0.030 |
Why?
| | Virulence Factors | 1 | 2016 | 79 | 0.030 |
Why?
| | Thioglycolates | 1 | 2014 | 3 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 587 | 0.030 |
Why?
| | Cathepsin D | 1 | 2014 | 4 | 0.030 |
Why?
| | Polysaccharides | 1 | 2015 | 57 | 0.030 |
Why?
| | Genome, Archaeal | 1 | 2014 | 2 | 0.030 |
Why?
| | Disease Progression | 1 | 2017 | 880 | 0.030 |
Why?
| | Vaccination | 1 | 2016 | 310 | 0.030 |
Why?
| | Risk Assessment | 1 | 2019 | 1368 | 0.030 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 7 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 28 | 0.030 |
Why?
| | Butyrates | 1 | 2014 | 30 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2014 | 188 | 0.030 |
Why?
| | Hardness | 1 | 2013 | 1 | 0.030 |
Why?
| | Adiposity | 1 | 2015 | 147 | 0.030 |
Why?
| | Models, Molecular | 1 | 2015 | 352 | 0.030 |
Why?
| | Weight Gain | 1 | 2015 | 245 | 0.030 |
Why?
| | Weaning | 1 | 2013 | 32 | 0.030 |
Why?
| | Esters | 1 | 2013 | 19 | 0.030 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2013 | 2 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 198 | 0.030 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2013 | 2 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2014 | 60 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 117 | 0.030 |
Why?
| | Sweden | 1 | 2013 | 11 | 0.030 |
Why?
| | Ergosterol | 1 | 2013 | 10 | 0.020 |
Why?
| | Cell Size | 1 | 2013 | 45 | 0.020 |
Why?
| | Bioengineering | 1 | 2013 | 3 | 0.020 |
Why?
| | NADP | 1 | 2013 | 23 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 670 | 0.020 |
Why?
| | Cell Separation | 1 | 2013 | 76 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 380 | 0.020 |
Why?
| | Tibia | 1 | 2013 | 118 | 0.020 |
Why?
| | G(M2) Ganglioside | 1 | 2013 | 1 | 0.020 |
Why?
| | Keratan Sulfate | 1 | 2013 | 1 | 0.020 |
Why?
| | Androsterone | 1 | 2013 | 2 | 0.020 |
Why?
| | Heparitin Sulfate | 1 | 2013 | 7 | 0.020 |
Why?
| | Penicillins | 1 | 2013 | 32 | 0.020 |
Why?
| | Classification | 1 | 2013 | 12 | 0.020 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2013 | 141 | 0.020 |
Why?
| | Demography | 1 | 2013 | 91 | 0.020 |
Why?
| | Species Specificity | 1 | 2013 | 191 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 12 | 0.020 |
Why?
| | Carbon Cycle | 1 | 2012 | 6 | 0.020 |
Why?
| | Environment | 1 | 2013 | 87 | 0.020 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 101 | 0.020 |
Why?
| | Aerosols | 1 | 2013 | 74 | 0.020 |
Why?
| | Complement Activation | 1 | 2012 | 27 | 0.020 |
Why?
| | Milk | 1 | 2013 | 84 | 0.020 |
Why?
| | Genetic Markers | 1 | 2012 | 104 | 0.020 |
Why?
| | Esterification | 1 | 2012 | 6 | 0.020 |
Why?
| | Xylose | 1 | 2012 | 4 | 0.020 |
Why?
| | Leptin | 1 | 2013 | 151 | 0.020 |
Why?
| | Bioreactors | 1 | 2012 | 10 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 659 | 0.020 |
Why?
| | Eubacterium | 1 | 2012 | 1 | 0.020 |
Why?
| | beta Carotene | 1 | 2012 | 9 | 0.020 |
Why?
| | Actinobacteria | 1 | 2012 | 11 | 0.020 |
Why?
| | Oxidoreductases | 1 | 2012 | 57 | 0.020 |
Why?
| | Immunity, Cellular | 1 | 2011 | 64 | 0.020 |
Why?
| | Sepsis | 1 | 2014 | 240 | 0.020 |
Why?
| | Administration, Intravaginal | 1 | 2011 | 3 | 0.020 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 88 | 0.020 |
Why?
| | Biological Phenomena | 1 | 2011 | 2 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 524 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 5595 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 580 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 355 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2012 | 489 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2010 | 50 | 0.020 |
Why?
| | Models, Animal | 1 | 2011 | 233 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 38 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 975 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 1136 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 742 | 0.020 |
Why?
| | Body Mass Index | 1 | 2013 | 717 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 338 | 0.020 |
Why?
| | Binding Sites | 1 | 2010 | 373 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2021 | 6819 | 0.020 |
Why?
| | Glucose | 1 | 2010 | 361 | 0.020 |
Why?
| | Ethanol | 1 | 2010 | 338 | 0.020 |
Why?
|
|
Nookaew's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|